140 related articles for article (PubMed ID: 26204491)
1. Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression.
Yang L; Fang D; Chen H; Lu Y; Dong Z; Ding HF; Jing Q; Su SB; Huang S
Oncotarget; 2015 Aug; 6(25):20801-12. PubMed ID: 26204491
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of the 19q12 amplicon in grade III breast cancers.
Natrajan R; Mackay A; Wilkerson PM; Lambros MB; Wetterskog D; Arnedos M; Shiu KK; Geyer FC; Langerød A; Kreike B; Reyal F; Horlings HM; van de Vijver MJ; Palacios J; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2012 Mar; 14(2):R53. PubMed ID: 22433433
[TBL] [Abstract][Full Text] [Related]
3. Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.
Caruso JA; Duong MT; Carey JPW; Hunt KK; Keyomarsi K
Cancer Res; 2018 Oct; 78(19):5481-5491. PubMed ID: 30194068
[TBL] [Abstract][Full Text] [Related]
4. AURKB promotes colorectal cancer progression by triggering the phosphorylation of histone H3 at serine 10 to activate CCNE1 expression.
Li L; Xie K; Xie H; Wang L; Li Z; Lu Q; Feng J
Aging (Albany NY); 2024 May; 16(9):8019-8030. PubMed ID: 38713155
[TBL] [Abstract][Full Text] [Related]
5. CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Kang EY; Weir A; Meagher NS; Farrington K; Nelson GS; Ghatage P; Lee CH; Riggan MJ; Bolithon A; Popovic G; Leung B; Tang K; Lambie N; Millstein J; Alsop J; Anglesio MS; Ataseven B; Barlow E; Beckmann MW; Berger J; Bisinotto C; Bösmüller H; Boros J; Brand AH; Brooks-Wilson A; Brucker SY; Carney ME; Casablanca Y; Cazorla-Jiménez A; Cohen PA; Conrads TP; Cook LS; Coulson P; Courtney-Brooks M; Cramer DW; Crowe P; Cunningham JM; Cybulski C; Darcy KM; El-Bahrawy MA; Elishaev E; Erber R; Farrell R; Fereday S; Fischer A; García MJ; Gayther SA; Gentry-Maharaj A; Gilks CB; ; Grube M; Harnett PR; Harrington SP; Harter P; Hartmann A; Hecht JL; Heikaus S; Hein A; Heitz F; Hendley J; Hernandez BY; Polo SH; Heublein S; Hirasawa A; Høgdall E; Høgdall CK; Horlings HM; Huntsman DG; Huzarski T; Jewell A; Jimenez-Linan M; Jones ME; Kaufmann SH; Kennedy CJ; Khabele D; Kommoss FKF; Kruitwagen RFPM; Lambrechts D; Le ND; Lener M; Lester J; Leung Y; Linder A; Loverix L; Lubiński J; Madan R; Maxwell GL; Modugno F; Neuhausen SL; Olawaiye A; Olbrecht S; Orsulic S; Palacios J; Pearce CL; Pike MC; Quinn CM; Mohan GR; Rodríguez-Antona C; Ruebner M; Ryan A; Salfinger SG; Sasamoto N; Schildkraut JM; Schoemaker MJ; Shah M; Sharma R; Shvetsov YB; Singh N; Sonke GS; Steele L; Stewart CJR; Sundfeldt K; Swerdlow AJ; Talhouk A; Tan A; Taylor SE; Terry KL; Tołoczko A; Traficante N; Van de Vijver KK; van der Aa MA; Van Gorp T; Van Nieuwenhuysen E; van-Wagensveld L; Vergote I; Vierkant RA; Wang C; Wilkens LR; Winham SJ; Wu AH; Benitez J; Berchuck A; Candido Dos Reis FJ; DeFazio A; Fasching PA; Goode EL; Goodman MT; Gronwald J; Karlan BY; Kommoss S; Menon U; Sinn HP; Staebler A; Brenton JD; Bowtell DD; Pharoah PDP; Ramus SJ; Köbel M
Cancer; 2023 Mar; 129(5):697-713. PubMed ID: 36572991
[TBL] [Abstract][Full Text] [Related]
6.
Xu H; George E; Kinose Y; Kim H; Shah JB; Peake JD; Ferman B; Medvedev S; Murtha T; Barger CJ; Devins KM; D'Andrea K; Wubbenhorst B; Schwartz LE; Hwang WT; Mills GB; Nathanson KL; Karpf AR; Drapkin R; Brown EJ; Simpkins F
Cell Rep Med; 2021 Sep; 2(9):100394. PubMed ID: 34622231
[No Abstract] [Full Text] [Related]
7. CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs.
Okimoto RA; Wu W; Nanjo S; Olivas V; Lin YK; Ponce RK; Oyama R; Kondo T; Bivona TG
J Clin Invest; 2019 Jul; 129(8):3401-3406. PubMed ID: 31329165
[TBL] [Abstract][Full Text] [Related]
8. CircROR1 upregulates CCNE1 expression to promote melanoma invasion and metastasis by recruiting KAT2A.
Sun L; Bin S; Huang C; Wang Q
Exp Dermatol; 2024 Apr; 33(4):e15071. PubMed ID: 38566477
[TBL] [Abstract][Full Text] [Related]
9. Targeting Therapeutic Resistance and Multinucleate Giant Cells in CCNE1-Amplified HR-Proficient Ovarian Cancer.
Bai S; Taylor SE; Jamalruddin MA; McGonigal S; Grimley E; Yang D; Bernstein KA; Buckanovich RJ
Mol Cancer Ther; 2022 Sep; 21(9):1473-1484. PubMed ID: 35732503
[TBL] [Abstract][Full Text] [Related]
10. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.
Fu YP; Kohaar I; Moore LE; Lenz P; Figueroa JD; Tang W; Porter-Gill P; Chatterjee N; Scott-Johnson A; Garcia-Closas M; Muchmore B; Baris D; Paquin A; Ylaya K; Schwenn M; Apolo AB; Karagas MR; Tarway M; Johnson A; Mumy A; Schned A; Guedez L; Jones MA; Kida M; Hosain GM; Malats N; Kogevinas M; Tardon A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Wu X; Purdue M; Andriole GL; Grubb RL; Black A; Landi MT; Caporaso NE; Vineis P; Siddiq A; Bueno-de-Mesquita HB; Trichopoulos D; Ljungberg B; Severi G; Weiderpass E; Krogh V; Dorronsoro M; Travis RC; Tjønneland A; Brennan P; Chang-Claude J; Riboli E; Prescott J; Chen C; De Vivo I; Govannucci E; Hunter D; Kraft P; Lindstrom S; Gapstur SM; Jacobs EJ; Diver WR; Albanes D; Weinstein SJ; Virtamo J; Kooperberg C; Hohensee C; Rodabough RJ; Cortessis VK; Conti DV; Gago-Dominguez M; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Haiman CA; Cussenot O; Cancel-Tassin G; Roupret M; Comperat E; Porru S; Carta A; Pavanello S; Arici C; Mastrangelo G; Grossman HB; Wang Z; Deng X; Chung CC; Hutchinson A; Burdette L; Wheeler W; Fraumeni J; Chanock SJ; Hewitt SM; Silverman DT; Rothman N; Prokunina-Olsson L
Cancer Res; 2014 Oct; 74(20):5808-18. PubMed ID: 25320178
[TBL] [Abstract][Full Text] [Related]
11. PPM1D activity promotes the replication stress caused by cyclin E1 overexpression.
Martinikova AS; Stoyanov M; Oravetzova A; Kok YP; Yu S; Dobrovolna J; Janscak P; van Vugt M; Macurek L
Mol Oncol; 2024 Jan; 18(1):6-20. PubMed ID: 37067201
[TBL] [Abstract][Full Text] [Related]
12. Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition.
Aziz D; Portman N; Fernandez KJ; Lee C; Alexandrou S; Llop-Guevara A; Phan Z; Yong A; Wilkinson A; Sergio CM; Ferraro D; Etemadmoghadam D; Bowtell DD; ; Serra V; Waring P; Lim E; Caldon CE
NPJ Breast Cancer; 2021 Aug; 7(1):111. PubMed ID: 34465787
[TBL] [Abstract][Full Text] [Related]
13. CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination.
Brown VE; Moore SL; Chen M; House N; Ramsden P; Wu HJ; Ribich S; Grassian AR; Choi YJ
NAR Cancer; 2023 Sep; 5(3):zcad039. PubMed ID: 37519629
[No Abstract] [Full Text] [Related]
14. Diagnostic value of cyclin-dependent kinase/cyclin-dependent kinase inhibitor expression ratios as biomarkers of locoregional and hematogenous dissemination risks in oral squamous cell carcinoma.
Nagata M; Kurita H; Uematsu K; Ogawa S; Takahashi K; Hoshina H; Takagi R
Mol Clin Oncol; 2015 Sep; 3(5):1007-1013. PubMed ID: 26623041
[TBL] [Abstract][Full Text] [Related]
15. WEE1i-ATRi combination therapy: a promising low-dose treatment for
Goehring L; Huang TT
Cell Rep Med; 2021 Sep; 2(9):100402. PubMed ID: 34622238
[No Abstract] [Full Text] [Related]
16. CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance.
Sapoznik S; Aviel-Ronen S; Bahar-Shany K; Zadok O; Levanon K
Oncotarget; 2017 Sep; 8(37):62240-62247. PubMed ID: 28977941
[TBL] [Abstract][Full Text] [Related]
17. Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.
Rustgi N; Wu S; Samec T; Walker P; Xiu J; Lou E; Goel S; Saeed A; Moy RH
Cancer Res Commun; 2024 May; ():. PubMed ID: 38717153
[TBL] [Abstract][Full Text] [Related]
18. Copy number variations and protein expression of Cyclin E1 and Epithelial cell transforming sequence 2 genes predict the chemotherapeutic response in patients with serous ovarian carcinoma.
Sarfraz R; Masood A; Zaki S; Shami A; Khaliq S; Naseem N
Pak J Med Sci; 2023; 39(3):835-842. PubMed ID: 37250533
[TBL] [Abstract][Full Text] [Related]
19. Accelerated Discovery of Macrocyclic CDK2 Inhibitor QR-6401 by Generative Models and Structure-Based Drug Design.
Yu Y; Huang J; He H; Han J; Ye G; Xu T; Sun X; Chen X; Ren X; Li C; Li H; Huang W; Liu Y; Wang X; Gao Y; Cheng N; Guo N; Chen X; Feng J; Hua Y; Liu C; Zhu G; Xie Z; Yao L; Zhong W; Chen X; Liu W; Li H
ACS Med Chem Lett; 2023 Mar; 14(3):297-304. PubMed ID: 36923916
[TBL] [Abstract][Full Text] [Related]
20. Targeting
Xu H; George E; Gallo D; Medvedev S; Wang X; Kryczka R; Hyer ML; Fourtounis J; Stocco R; Aguado-Fraile E; Petrone A; Yin SY; Shiwram A; Anderson M; Kim H; Liu F; Marshall CG; Simpkins F
Res Sq; 2024 Feb; ():. PubMed ID: 38410486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
